Suprasorb® A + Ag in the Treatment of Wounds at Risk of Infection and Infected Wounds
NCT05646121 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 99
Last updated 2024-01-26
Summary
The aim of this post market clinical follow up (PMCF) study is to confirm the performance of Suprasorb® A + Ag wound dressing and rope, to collect safety data regarding expected adverse events and to detect potential unexpected adverse events associated with use of Suprasorb® A + Ag wound dressing and rope within the certified indications and under the conditions of routine use.
Conditions
- Pressure Ulcer
- Arterial Ulcers
- Venous Leg Ulcer
- Diabetic Ulcers
- Surgical Wound
- Skin Graft
Interventions
- DEVICE
-
Suprasorb® A + Ag wound dressing and rope
Suprasorb® A + Ag Antimicrobial Calcium Alginate Wound Dressings / Packing Rope are soft, conformable wound coverings with a high mannuronic acid content (mass per unit area ≥100 g/m2). The silver impregnated calcium alginate fibres react with wound exudate or blood to form a gel which creates a moist wound environment. The silver contained in the wound dressing has broad antimicrobial activity, including against MRSA and VRE. Antimicrobial action (\>3 log steps) associated with the ionic silver from the silver alginate fibres (1.5%) is observed in vitro after just 24 h and this remains stable for up to seven days
Sponsors & Collaborators
-
Lohmann & Rauscher
lead INDUSTRY
Principal Investigators
-
Claudia Feldkamp, Dr. · Lohmann & Rauscher
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-09-13
- Primary Completion
- 2023-12-05
- Completion
- 2023-12-05
Countries
- Poland
Study Locations
More Related Trials
-
Aquacel With Strengthening Fiber (WSF) Ribbon Dressings
NCT07308665 ·Status: COMPLETED
-
Activated Carbon Interphase Effect on Surgical Incisions vs.Two Common Wound Dressings
NCT04038671 ·Status: WITHDRAWN ·Phase: NA
-
Suprathel® Use During Prolonged Field Care to Promote Healing and Reduce the Need for Grafting of Burn Wounds
NCT05462860 ·Status: RECRUITING ·Phase: NA
-
Elimination of Odor and Treatment of Malodorous Recalcitrant Wounds by Using Supraz and PRP-FG Versus Standard of Care
NCT05983302 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Evaluation of the Feasibility, Safety, Initial Efficacy and Clinical Usability of FuseX Anti-Adhesion System
NCT03820713 ·Status: COMPLETED ·Phase: NA
-
Post-Market Clinical Evaluation of the Spiracur SNaP Wound Care System for Treatment of Acute Trauma and Acute Surgical Excision Wounds
NCT01417234 ·Status: COMPLETED
-
A Comparative Study to Assess the Prevention of Surgical Site Infection (SSI's) in Revision Total Joint Arthroplasty Patients Treated With Single-Use Negative Pressure Wound Therapy (PICO™) or Standard Care Dressings (AQUACEL® Ag SURGICAL Dressing)
NCT02664168 ·Status: UNKNOWN ·Phase: NA
-
Safety and Performance of SWIS in Superficial Wounds
NCT04771819 ·Status: COMPLETED ·Phase: NA
-
A Comparative Efficacy and Safety Study Between Two Silver Containing Dressings In Post-Op Wound Healing
NCT01605968 ·Status: TERMINATED ·Phase: NA
-
Evaluation of a Management Strategy for Second-degree Fibrinous Burns Integrating a Poly-absorbent Dressing
NCT05347654 ·Status: COMPLETED ·Phase: NA
-
Effect of the Negative Pressure Therapy Dressing Compared With Hydrogel Dressing.
NCT04265612 ·Status: TERMINATED ·Phase: NA
-
Confirm Performance and Safety of Exufiber When Used as Intended on Donor Sites
NCT04884568 ·Status: COMPLETED ·Phase: NA
-
To Evaluate the Safety and Performance of the AMS ActivHeal Silicone Foam and the ActivHeal Silicone Foam Lite Dressing.
NCT04621838 ·Status: COMPLETED ·Phase: NA
-
PMS Study of Silver I Alginate Non-Woven Dressing (Hydro-Alginate)
NCT05690685 ·Status: COMPLETED ·Phase: NA
-
A Randomized Comparison Study of Aquacel Ag and Glucan II as Donor Site Dressings
NCT00581217 ·Status: TERMINATED
-
Comparative Evaluation of Two AQUACEL Ag Protocols of Care for the Management of Donor Sites
NCT00731367 ·Status: COMPLETED ·Phase: PHASE3
-
Microcurrent for Healing Autogenous Skin Donor Sites
NCT00558701 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess Wound Healing Efficacies of Different Clean, Treat, and Protect Wound Care Regimens Compared to Standard of Care and Untreated
NCT05045183 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study of a New Antimicrobial Wound Dressing to Treat Wounds Caused by Curettage and Electrodesiccation
NCT00816101 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of the Investigational Device, SurgiShield Anti-Adhesion Barrier Gel
NCT01895933 ·Status: COMPLETED ·Phase: NA
-
Study to Examine Clinical Performance and Safety of Cutimed® Gelling Fiber in Routine Clinical Practice
NCT05148390 ·Status: COMPLETED
-
Surgicel Snow in Gynecological Surgery
NCT02908841 ·Status: COMPLETED ·Phase: NA
-
Clinical Evaluation of the SNaP Wound Care System
NCT01113658 ·Status: WITHDRAWN ·Phase: NA
-
Safety Study of Polylactide-Caprolactone-Trimethylenecarbonate Copolymer for Post-Operative Adhesion Prophylaxis
NCT00597662 ·Status: COMPLETED ·Phase: PHASE1
-
TWB-103 for Adult Patients With Split-Thickness Skin Graft Donor Site Wounds
NCT02737748 ·Status: COMPLETED ·Phase: PHASE1/PHASE2